<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1712">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05138874</url>
  </required_header>
  <id_info>
    <org_study_id>R01HS026506</org_study_id>
    <nct_id>NCT05138874</nct_id>
  </id_info>
  <brief_title>Improving Safe Antibiotic Prescribing in Telehealth</brief_title>
  <official_title>Improving Safe Antibiotic Prescribing in Telehealth: Evaluation of a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Teladoc Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Appropriate use of antibiotics reduces resistance and protects patients from unnecessary&#xD;
      harm. Important advances in antibiotic stewardship have been achieved in outpatient settings,&#xD;
      but little is known about stewardship in the rapidly growing telehealth sector. Prior&#xD;
      pragmatic randomized trials have shown that Centers for Disease Control (CDC) Core Element&#xD;
      interventions constructed using insights from decision and social psychology can greatly&#xD;
      reduce inappropriate prescribing in outpatient settings.&#xD;
&#xD;
      In a randomized trial, the investigators will adapt and test two aspects of CDC Core Elements&#xD;
      in a telehealth environment (Teladoc®), each with two levels of intensity. Teladoc®&#xD;
      clinicians will be randomized to the following interventions: 1) Performance Feedback&#xD;
      (Trending, Benchmark Peer Comparison), 2) Commitment (Private, Public), or 3) Control. All&#xD;
      randomization occurs at the provider level, with the exception of the Public Commitment arm,&#xD;
      which requires patient-facing content that is determined by patient state. Clinicians and&#xD;
      members will see the same messages across all pages, all channels &amp; all consults during the&#xD;
      12-month study period. The primary outcome is to assess change in antibiotic prescribing rate&#xD;
      for qualifying acute respiratory infection visits (ARIs).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a 3 x 3 (Performance Feedback x Commitment) randomized trial, the investigators will adapt&#xD;
      and test two aspects of Core Elements in a telehealth environment (Teladoc®), each with two&#xD;
      variations. Qualifying visits include pediatric and adult telehealth visits for acute&#xD;
      respiratory infections, including sinusitis, bronchitis, influenza, otitis media,&#xD;
      pharyngitis, nonspecific upper respiratory infections, and COVID-19.&#xD;
&#xD;
      All randomization occurs at the provider level, with the exception of the Public Commitment&#xD;
      arm, which requires patient-facing content that is determined by patient state. Allocation&#xD;
      will be stratified to ensure balance across baseline characteristics including visit volume&#xD;
      (consults per year), antibiotic prescribing rate for acute respiratory infections and&#xD;
      COVID-19, and average member satisfaction (percent of responses &quot;Outstanding&quot; or &quot;Good&quot;).&#xD;
&#xD;
      Performance Feedback (Trending, Benchmark Peer Comparison, Control). Performance Feedback is&#xD;
      based on regional performance benchmarks; physicians with antibiotic prescribing rates in the&#xD;
      lowest 3 deciles are designated top performers. The electronic health record (EHR) metrics&#xD;
      and messaging are designed to align with enterprise-wide performance feedback practices. A&#xD;
      minimum of 8 qualifying visits is required for a provider to see a message.&#xD;
&#xD;
      Providers randomized to Performance Feedback interventions will see one of two feedback&#xD;
      messages in the EHR:&#xD;
&#xD;
        1. Trending Feedback Message: If the clinician's mean monthly antibiotic prescribing rate&#xD;
           for acute respiratory infections is below the 3rd decile, where better performance is&#xD;
           indicated by a position in a lower decile, providers will see the following message with&#xD;
           a link to the clinical practice guidelines: &quot;Your antibiotic prescribing rate is X%.&#xD;
           Stay in the growing number of providers in your group that have stopped inappropriate&#xD;
           antibiotic prescribing.&quot; If the clinician's mean monthly antibiotic prescribing rate for&#xD;
           ARIs is above the 3rd decile where better performance is indicated by a position in a&#xD;
           lower decile, providers will see the following message with a link to the clinical&#xD;
           practice guidelines: &quot;Your antibiotic prescribing rate is Y% (where Y% is the&#xD;
           prescribing rate of the third decile). Don't be left behind! Join the growing number of&#xD;
           providers in your group who prescribe antibiotics only when clearly indicated.&quot;&#xD;
&#xD;
        2. Benchmark Peer Comparison Feedback Message: If the clinician's mean monthly antibiotic&#xD;
           prescribing rate for ARIs is below the 3rd decile, where better performance is indicated&#xD;
           by a position in a lower decile, providers will receive the following message: &quot;You are&#xD;
           a Top Performer. Your antibiotic prescribing rate is X%. Top performers in your group&#xD;
           typically prescribe antibiotics in X% of visits.&quot; If the clinician prescribing rate is&#xD;
           above the 3rd decile, where better performance is indicated by a position in a lower&#xD;
           decile, providers will receive the following message: &quot;You are not a Top Performer. Top&#xD;
           performers in your group typically prescribe antibiotics in Y% of visits.&quot;&#xD;
&#xD;
      Commitment (Private, Public, Control). Clinicians assigned to the Private Commitment arm will&#xD;
      make a personal commitment to evidence-based use of antibiotics that is not shared with their&#xD;
      patients, while those assigned to Public Commitment will make a commitment to evidence-based&#xD;
      use of antibiotics that is shared with their patients. For both arms, this commitment is&#xD;
      displayed on the clinician's personal provider dashboard.&#xD;
&#xD;
      Providers randomized to the Commitment interventions will be asked to complete one of two&#xD;
      commitments:&#xD;
&#xD;
        1. Private Commitment: Providers will be given the following options:1) Record my&#xD;
           commitment or 2) Do not include me in the commitment, followed by a text box to type&#xD;
           their name. For clinicians who choose option 1, their commitment is displayed on their&#xD;
           personal provider dashboard at the time of each login.&#xD;
&#xD;
        2. Public Commitment: Providers will be given the following options:1) Record and share my&#xD;
           commitment with my patients OR 2) I am not committed to the new guidelines, followed by&#xD;
           a text box to type their name. For clinicians who opt in, the commitment is displayed on&#xD;
           their personal dashboard at each login.&#xD;
&#xD;
      Patients in states assigned to Public Commitment will see the clinician's commitment at the&#xD;
      end of their visit request. Patients will select: 1) I understand the provider's commitment&#xD;
      OR 2) I do not understand and need more information. Clinicians in this arm will be notified&#xD;
      about the patient response in the EHR during the visit.&#xD;
&#xD;
      The primary outcome is to assess the change in antibiotic prescribing rate for qualifying&#xD;
      acute respiratory infection visits.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Participants are randomly assigned to one of three levels of commitment interventions and one of three levels of feedback interventions, for a total of 9 study arms (3 X 3). One level in each factor is &quot;control&quot; which entails &quot;no intervention&quot;.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Patients are blinded to all study arms with the exception of Public Commitment where, by design, patients are exposed to physicians' commitment. Physicians cannot be blinded to interventions that, by design, impact the electronic medical record display.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in antibiotic prescribing rate for Acute Respiratory Infections</measure>
    <time_frame>12 months</time_frame>
    <description>Change in antibiotic prescribing rate for acute respiratory infection visits based on the International Statistical Classification of Diseases, version 10 (ICD-10) codes including: non-specific upper respiratory infections, otitis media, sinusitis, pharyngitis, bronchitis, influenza, and COVID-19.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in inappropriate antibiotic prescribing rate for Acute Respiratory Infections</measure>
    <time_frame>12 months</time_frame>
    <description>Change in inappropriate antibiotic prescribing rate for acute respiratory infections where antibiotics are never appropriate based on International Statistical Classification of Diseases, version 10 (ICD-10) codes as well as COVID-19 (U07.1)</description>
  </secondary_outcome>
  <number_of_arms>9</number_of_arms>
  <enrollment type="Anticipated">5762</enrollment>
  <condition>Acute Respiratory Infection</condition>
  <condition>Telehealth</condition>
  <arm_group>
    <arm_group_label>Trending Feedback + Private Commitment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive both Trending Feedback + Private Commitment interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trending Feedback + Public Commitment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive both Trending Feedback + Public Commitment interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trending Feedback + Commitment Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive Trending Feedback intervention + Commitment Control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Benchmark Peer Comparison Feedback + Private Commitment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive both Benchmark Peer Comparison Feedback + Private Commitment interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Benchmark Peer Comparison Feedback + Public Commitment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive both Benchmark Peer Comparison Feedback + Public Commitment interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Benchmark Peer Comparison Feedback + Commitment Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive Benchmark Peer Comparison Feedback intervention + Commitment Control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Public Commitment + Feedback Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive Public Commitment intervention + Feedback Control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Private Commitment + Feedback Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians receive Private Commitment intervention + Feedback Control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Commitment Control + Feedback Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Clinicians receive no intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Trending Feedback</intervention_name>
    <description>Clinicians randomized to Trending Feedback will receive monthly feedback on the provider dashboard page.</description>
    <arm_group_label>Trending Feedback + Commitment Control</arm_group_label>
    <arm_group_label>Trending Feedback + Private Commitment</arm_group_label>
    <arm_group_label>Trending Feedback + Public Commitment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Benchmark Peer Comparison Feedback</intervention_name>
    <description>Clinicians randomized to Benchmark Peer Comparison Feedback will receive monthly feedback on the provider dashboard page.</description>
    <arm_group_label>Benchmark Peer Comparison Feedback + Commitment Control</arm_group_label>
    <arm_group_label>Benchmark Peer Comparison Feedback + Private Commitment</arm_group_label>
    <arm_group_label>Benchmark Peer Comparison Feedback + Public Commitment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Private Commitment</intervention_name>
    <description>Clinicians assigned to the Private Commitment will be prompted in the provider dashboard to make a personal commitment to evidence-based use of antibiotics that will not be shared with their patients.</description>
    <arm_group_label>Benchmark Peer Comparison Feedback + Private Commitment</arm_group_label>
    <arm_group_label>Private Commitment + Feedback Control</arm_group_label>
    <arm_group_label>Trending Feedback + Private Commitment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Public Commitment</intervention_name>
    <description>Clinicians assigned to Public Commitment will be prompted in the provider dashboard to make a commitment to evidence-based use of antibiotics that will be shared with their patients.</description>
    <arm_group_label>Benchmark Peer Comparison Feedback + Public Commitment</arm_group_label>
    <arm_group_label>Public Commitment + Feedback Control</arm_group_label>
    <arm_group_label>Trending Feedback + Public Commitment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinicians with prescribing privileges and one or more Acute Respiratory Infection&#xD;
             visit&#xD;
&#xD;
          -  Eligible encounters include pediatric and adult telehealth visits for Acute&#xD;
             Respiratory Infections, including Sinusitis, Bronchitis, Influenza, Otitis Media,&#xD;
             Nasopharyngitis, Upper Respiratory Infections, and COVID-19.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniella Meeker, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Teladoc Health</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75244</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Chua KP, Fischer MA, Linder JA. Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional study. BMJ. 2019 Jan 16;364:k5092. doi: 10.1136/bmj.k5092.</citation>
    <PMID>30651273</PMID>
  </reference>
  <reference>
    <citation>Meeker D, Knight TK, Friedberg MW, Linder JA, Goldstein NJ, Fox CR, Rothfeld A, Diaz G, Doctor JN. Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial. JAMA Intern Med. 2014 Mar;174(3):425-31. doi: 10.1001/jamainternmed.2013.14191.</citation>
    <PMID>24474434</PMID>
  </reference>
  <reference>
    <citation>Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Knight TK, Hay JW, Doctor JN. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. JAMA. 2016 Feb 9;315(6):562-70. doi: 10.1001/jama.2016.0275.</citation>
    <PMID>26864410</PMID>
  </reference>
  <reference>
    <citation>Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core Elements of Outpatient Antibiotic Stewardship. MMWR Recomm Rep. 2016 Nov 11;65(6):1-12. doi: 10.15585/mmwr.rr6506a1.</citation>
    <PMID>27832047</PMID>
  </reference>
  <reference>
    <citation>Linder JA, Meeker D, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Doctor JN. Effects of Behavioral Interventions on Inappropriate Antibiotic Prescribing in Primary Care 12 Months After Stopping Interventions. JAMA. 2017 Oct 10;318(14):1391-1392. doi: 10.1001/jama.2017.11152.</citation>
    <PMID>29049577</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>November 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Daniella Meeker</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>antibiotics</keyword>
  <keyword>behavioral economics</keyword>
  <keyword>social norms</keyword>
  <keyword>performance feedback</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

